Blood News and Research

RSS

New tool enables doctors to monitor infections, inflammation and scarring in lungs

Intensive care patients who are on breathing support could be helped by a new tool to enable doctors to see inside their lungs to check for and monitor infections, inflammation and scarring.

4 Jun 2013

Study: Blood vessels in retina may indicate brain health years before onset of dementia

The width of blood vessels in the retina, located at the back of the eye, may indicate brain health years before the onset of dementia and other deficits, according to a new study published in Psychological Science, a journal of the Association for Psychological Science.

4 Jun 2013

Interval between pregnancies: A golden window for obese women to lose weight

The time between pregnancies is a golden window for obese women to lose weight, a Saint Louis University study finds.

4 Jun 2013

Researchers identify ways to inhibit function of key protein linked to stem cell-like behavior in CML

A research team led by the Duke-NUS Graduate Medical School in Singapore has identified ways to inhibit the function of a key protein linked to stem cell-like behavior in terminal-stage chronic myeloid leukemia, making it possible to develop drugs that may extend the survival of these patients.

4 Jun 2013

People with type 2 diabetics, hypertension more likely to have obstructive sleep apnea: Study

The American Academy of Sleep Medicine is advising anyone with Type 2 diabetes or hypertension to be evaluated for sleep apnea by a board-certified sleep medicine physician. The recommendation comes as the group of international clinicians and researchers meets in Baltimore for SLEEP 2013, the foremost gathering of sleep experts annually.

4 Jun 2013

Data from Nivolumab phase I study in patients with kidney cancer to be presented at ASCO 2013

Researchers at Dartmouth-Hitchcock Norris Cotton Cancer Center will present a poster on a phase I clinical trial of Nivolumab, a PD-1 receptor blocking antibody, being used in combination with other drugs in patients with metastatic renal cell carcinoma at the ASCO Annual Meeting on June 3, 2013.

4 Jun 2013

Experts call for international consensus on criteria used to diagnose circulatory and neurological death

The criteria used to diagnose both circulatory and brain death in a patient are subject to variability and as such can be controversial. Anaesthesiologists play an important role in procedures related to the determination of death, so should have specific knowledge about medical, ethical and legal criteria of brain death definition.

3 Jun 2013

Mathematical modeling proved critical in understanding latent stage of infections

Recurrent infection is a common feature of persistent viral diseases. It includes episodes of high viral production interspersed by periods of relative quiescence. These quiescent or silent stages are hard to study with experimental models. Mathematical analysis can help fill in the gaps.

3 Jun 2013

Phase I/II study shows safety and efficacy of VB-111 in patients with rGBM

VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced clinical data demonstrating the utility of VB-111's in targeted cancer treatment.

3 Jun 2013

NJIT professor emphasizes how point of care healthcare can reduce illness, improve quality of life

NJIT Distinguished Professor and electrical engineer Atam Dhawan hits the lecture trail again this summer as a distinguished speaker for an IEEE life sciences lecture series.

3 Jun 2013

It is possible to reduce salt content without reducing the taste

It is entirely possible to reduce the salt content in a range of foods by up to 30% without reducing the taste.

3 Jun 2013

EKF Diagnostics launches rapid strip-based test for hemoglobin at ISBT

EKF, has announced the global launch of a new strip-based test for quick and easy hemoglobin analysis for anemia determination.

From EKF Diagnostics 3 Jun 2013

Research: Bevacizumab fails to increase overall survival for glioblastoma patients

The angiogenesis inhibitor bevacizumab (Avastin) failed to increase overall survival (OS) or statistically significant progression-free survival (PFS) for glioblastoma patients in the frontline setting, according to research led by researchers at The University of Texas MD Anderson Cancer Center.

3 Jun 2013

Activ8rlives 2.0 goes live with new self monitoring capabilities for health and wellness

Activ8rlives’ website version 2.0 has now gone live after several months of preparation and testing. Activ8rlives focuses its online self monitoring solutions for health and wellness, which is utilized by families, groups and companies.

3 Jun 2013

Researchers solve two longstanding challenges in liver tissue engineering

Prometheus, the mythological figure who stole fire from the gods, was punished for this theft by being bound to a rock. Each day, an eagle swept down and fed on his liver, which then grew back to be eaten again the next day.

3 Jun 2013

Study investigates gene expression signature to predict response to bevacizumab

A new test may help identify newly diagnosed glioblastoma patients more likely to benefit from bevacizumab (Avastin-), according to new research from The University of Texas MD Anderson Cancer Center.

3 Jun 2013

Experts to discuss on resuscitation efforts at Euroanaesthesia

One of the most difficult moments faced by anaesthetists and other healthcare staff is when to carry on attempts to resuscitate a person, and when those efforts should reasonably stop. This dilemma is the subject of a session at Euroanaesthesia, the annual congress of the European Society of Anaesthesiology.

3 Jun 2013

Human tumors with MET amplification respond to MET inhibitor drugs

A subset of colorectal cancers responds to anti-epidermal growth factor receptor (anti-EGFR) therapies, but develops resistance within months. Among cancers that develop resistance to anti-EGFR therapy, some showed overexpression of a gene called MET, according to a study published in the June issue of Cancer Discovery, a journal of the American Association for Cancer Research.

3 Jun 2013

Sorafenib stops tumor growth, provides effective treatment for thyroid cancer patients

The kidney and liver cancer drug sorafenib holds metastatic thyroid cancer at bay for nearly twice as long as a placebo, according to results of a randomized phase III trial, which will be presented today by a researcher from the Abramson Cancer Center and the Perelman School of Medicine at the University of Pennsylvania in a plenary session during the American Society of Clinical Oncology's annual meeting.

3 Jun 2013

Researchers find that stress of poverty influences health costs among resilient kids

Children living in poverty who appear to succeed socially may be failing biologically. Students able to overcome the stress of growing up poor are labeled "resilient" because of their ability to overcome adversity, but University of Georgia researchers found this resiliency has health costs that last well into adulthood.

3 Jun 2013

Blood News and Research

New tool enables doctors to monitor infections, inflammation and scarring in lungs

Study: Blood vessels in retina may indicate brain health years before onset of dementia

Interval between pregnancies: A golden window for obese women to lose weight

Researchers identify ways to inhibit function of key protein linked to stem cell-like behavior in CML

People with type 2 diabetics, hypertension more likely to have obstructive sleep apnea: Study

Data from Nivolumab phase I study in patients with kidney cancer to be presented at ASCO 2013

Experts call for international consensus on criteria used to diagnose circulatory and neurological death

Mathematical modeling proved critical in understanding latent stage of infections

Phase I/II study shows safety and efficacy of VB-111 in patients with rGBM

NJIT professor emphasizes how point of care healthcare can reduce illness, improve quality of life

It is possible to reduce salt content without reducing the taste

EKF Diagnostics launches rapid strip-based test for hemoglobin at ISBT

Research: Bevacizumab fails to increase overall survival for glioblastoma patients

Activ8rlives 2.0 goes live with new self monitoring capabilities for health and wellness

Researchers solve two longstanding challenges in liver tissue engineering

Study investigates gene expression signature to predict response to bevacizumab

Experts to discuss on resuscitation efforts at Euroanaesthesia

Human tumors with MET amplification respond to MET inhibitor drugs

Sorafenib stops tumor growth, provides effective treatment for thyroid cancer patients

Researchers find that stress of poverty influences health costs among resilient kids

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Latest News